751738
Last Update Posted: 2017-02-01
Recruiting has ended
All Genders accepted | 18 Years + |
330 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs)
This is an open-label, multi-center, long-term, (open-ended) safety study with 125 mg per day of azimilide in patients who completed protocol 2000098.
Eligibility
Relevant conditions:
Arrhythmias
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov